Geoffrey M. Price - Jan 10, 2023 Form 4 Insider Report for Oak Street Health, Inc. (OSH)

Role
Chief Innovation Officer, Director
Signature
/s/ Robert Guenthner, attorney-in-fact for Geoffrey Price
Stock symbol
OSH
Transactions as of
Jan 10, 2023
Transactions value $
-$436,835
Form type
4
Date filed
1/12/2023, 06:05 PM
Previous filing
Sep 7, 2022
Next filing
Feb 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSH Common Stock, $0.001 par value Options Exercise $1.05M +50K +1.31% $21.00 3.87M Jan 10, 2023 Direct F1
transaction OSH Common Stock, $0.001 par value Sale -$1.49M -50K -1.29% $29.74 3.82M Jan 10, 2023 Direct F1, F2
holding OSH Common Stock, $0.001 par value 3.87M Jan 10, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSH Employee Stock Option (Right to Buy) Options Exercise $0 -50K -14.14% $0.00 304K Jan 10, 2023 Common Stock, par value $0.001 50K $21.00 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.71 to $29.75, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote (2) to this Form 4.
F3 The options was fully vested and exercisable on August 5, 2020, the date it was granted.